Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Newling

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|April 6, 2001
Don't dismiss the floating kidneyD W Newling
European Urology|January 1, 1996
The management of hormone refractory prostate cancerD W Newling
Progress in Clinical and Biological Research|January 1, 1988
The advantages of staged cystectomy and urinary diversion in the management of invasive bladder cancerD W Newling
The Prostate. Supplement|January 1, 1992
What is 'progression' in prostate cancer?D W Newling
European Urology|January 1, 1997
Facing progressive localized prostatic cancerD W Newling
Progress in Clinical and Biological Research|January 1, 1987
The value of reversible androgen suppression as a diagnostic testD W Newling
European Urology|January 1, 1993
Management of relapsed prostatic carcinoma following primary treatmentD W Newling
Progress in Clinical and Biological Research|January 1, 1985
Criteria for response to treatment of metastatic prostatic cancerD W Newling
Progress in Clinical and Biological Research|January 1, 1985
Superficial bladder cancer--the need for long-term follow-up of clinical trialsD W Newling
Archivio Italiano Di Urologia, Nefrologia, Andrologia : Organo Ufficiale Dell'Associazione Per La Ricerca in Urologia = Urological, Nephrological, and Andrological Sciences|March 1, 1988
Tumor markers in bladder cancerD W Newling
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|April 6, 2001
Don't dismiss the floating kidneyD W Newling
European Urology|January 1, 1996
The management of hormone refractory prostate cancerD W Newling
Progress in Clinical and Biological Research|January 1, 1988
The advantages of staged cystectomy and urinary diversion in the management of invasive bladder cancerD W Newling
The Prostate. Supplement|January 1, 1992
What is 'progression' in prostate cancer?D W Newling
European Urology|January 1, 1997
Facing progressive localized prostatic cancerD W Newling
Progress in Clinical and Biological Research|January 1, 1987
The value of reversible androgen suppression as a diagnostic testD W Newling
European Urology|January 1, 1993
Management of relapsed prostatic carcinoma following primary treatmentD W Newling
Progress in Clinical and Biological Research|January 1, 1985
Criteria for response to treatment of metastatic prostatic cancerD W Newling
Progress in Clinical and Biological Research|January 1, 1985
Superficial bladder cancer--the need for long-term follow-up of clinical trialsD W Newling
Archivio Italiano Di Urologia, Nefrologia, Andrologia : Organo Ufficiale Dell'Associazione Per La Ricerca in Urologia = Urological, Nephrological, and Andrological Sciences|March 1, 1988
Tumor markers in bladder cancerD W Newling
Pageof 11